Latest receivables for SGFY: $180M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2022), SGFY shows a receivables of $180M. That compares with $220M in the prior-year period — down 15.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SGFY's receivables is now $180M (was $220M) — a 15.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Signify Health is outperforming or lagging.
Tracking SGFY's receivables over time shows whether Signify Health is scaling, shrinking, or reshaping that part of the business. The current reading is $180M That compares with $220M in the prior-year period — down 15.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Signify Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $180M) with ownership activity and broader fundamentals.
Signify Health's receivables is $180M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.